131I - Oncidium Foundation

I-131-Tositumomab (Bexxar®)

131I-Tositumomab is a radiolabeled anti-CD20 antibody launched in 2003 under [...]

support dev2022-04-25T15:10:45+00:00

131I-Lipiodol (131I-Ethiodized Oil) is a generic therapeutic agent which was [...]

support dev2022-04-25T15:19:27+00:00

131I-CAM-H2 (131I-SGMIB anti-HER2-VHH1) is a targeted radionuclide therapeutic drug (TRNT) [...]

support dev2022-10-07T16:32:05+00:00

131I-Naxitamab (131I-3F8) is a murine antibody targeting GD2 (disialoganglioside), labeled [...]

support dev2022-10-10T14:38:05+00:00

131I-Omburtamab (131I-Burtomab, 131I-8H9) is a monoclonal murine antibody, labeled [...]

support dev2022-10-10T14:41:24+00:00

131I-RPS-001 (131I-MIP-1095) is a small radiolabeled molecule, a glutamate-urea-lysine analogue, [...]

support dev2022-10-10T14:43:27+00:00

131I-Metuximab (brand name Licartin) is a radiolabeled murine antibody [...]

support dev2022-10-07T14:00:07+00:00

131I-Weimeisheng (131I-Tumor Necrosis Therapy mAb injection) is a radiolabeled [...]

support dev2022-10-07T14:05:04+00:00

131I-ICF01012 is a quite old product which eventually entered [...]

support dev2022-10-11T10:30:16+00:00